Fact.MR – A Market research and competitive intelligence provider: The global contraceptives market shall surpass a market valuation of US$ 37,242.7 Mn by the end of 2025.
Introduction Of New, Innovative And Low-Cost Contraceptive To Significantly Leverage The Contraceptive Market
The Fact.MR market study on the contraceptive market provides deep dive into key developments in the Contraceptive market. The report offers a comprehensive analysis of leading segments in terms of product type, distribution type, key regions.
Fact.MR – A Market research and competitive intelligence provider: The global contraceptives market shall surpass a market valuation of US$ 37,242.7 Mn by the end of 2025. Demand for contraceptives to register a robust market size of 6.4% CAGR during the forecast period (2020-2025).
Most unwanted pregnancies occur among adolescents and young women in the puberty period. Such pregnancies are a major source of the regularity of sexually transmitted diseases (STDs) such as HIV, chlamydia, genital herpes, and hepatitis B.
Other trends, notably the introduction of new, innovative, and low-cost contraceptive devices by key market players are also expected to significantly leverage the contraceptive market.
For Critical Insights on This Market, Request for More Info
https://www.factmr.com/connectus/sample?flag=S&rep_id=4719
The COVID-19 pandemic is impassive to bring about a downturn in the sales of contraceptives, owing to social distancing and limited physical contact among young people. The global supply of external physical barriers such as condoms shall experience a drop, owing to tighter border restrictions regarding import and export of products and reduced production.
These include nausea, headache, weight gain, increased bleeding, dysmenorrhea, and menstrual changes. Moreover, the introduction of custom-fit condoms by key market players is expected to burgeon the segment’s market share.
The COVID-19 pandemic is poised to bring about a downturn in the sales of contraceptives, owing to social distancing and limited physical contact among young people.
Key takeaways:
- North America is expected to surpass a market valuation of US$ 12,987.4 by 2025 and its projected market size of CAGR for the same is pegged at 6.6% during the forecast period.
- Asia-Pacific is projected to surpass a market value of US$ 7,925.7 by the end of 2025, expanding market size at a CAGR of 6.8%.
- By product type, Contraceptive devices are projected to capture a market size of more than half of the global contraceptives market during the forecast period, and is projected market size CAGR for the contraceptive devices segment is pegged at 6.6% during the forecast period.
Growth Drivers:
- In the wake of the growing prevalence of casual pregnancies, there is rising demand for reversible contraceptives in the contraceptive market.
- High incidence of the spread of STDs due to a rapidly expanding population is a key motivator for the expansion of the contraceptives market.
To gain in-depth insights on the Contraceptive Market, request methodology at:
https://www.factmr.com/connectus/sample?flag=RM&rep_id=4719
Competitive Landscape:
The competitive landscape of the Contraceptive Market focuses on unwanted pregnancies occurring among adolescents and young women. So, there is a rise in awareness about modern contraceptives.
- Agile Therapeutics is performing a stage 3 trial for Twirla, a contraceptive patch designed to deliver a low daily dose of estrogen.
- Merck & Co, Inc. provides contraceptive tablets, vaginal rings, intrauterine devices, and subdermal implants. Cyclessa, Desogen, NuvaRing, Implanon, and Nexplanon are some of the most popular products.
Key Companies Profiled by Fact.MR
- Allergen Plc
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Janssen Pharmaceutical Company
More valuable insights on the Contraceptive Market:
Fact.MR, in its report, offers a market analysis of the global Contraceptive Market the forecast period through 2020 and beyond. This survey reveals the growth of sports in the Contraceptive Market with detailed segmentation as follows
Product Type
- Contraceptive drugs (hormonal):
- Oral Contraceptives:
- Combined Contraceptives
- Mini pills
- Contraceptive Injectable
- Topical Contraceptive Patch
- Contraceptive Devices:
- Male Contraceptive Devices
- Female Contraceptive Devices:
- Female Condoms
- Contraceptive Diaphragms
- Contraceptive Sponges
- Contraceptive Vaginal Rings
- Intrauterine Devices
- Sub-dermal Contraceptive Implants
- Non-surgical Permanent Contraception Devices
Distribution Channel
- Hospital Pharmacy:
- Public
- Private
- Independent Pharmacy
- Online Platform
- Clinics
- Others
Key Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Questions covered in the Contraceptive Market Report
- The report offers insight into the contraceptive Market demand outlook for 2020-2025
- The market study also highlights projected sales growth for the contraceptive Market between 2020 and 2025
- Contraceptive Market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Contraceptive Market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain-
Contraceptive Rings Market Scope: Contraceptive rings are smooth, flexible round-shaped plastic rings that are meant to insert into the vagina on the first-day woman’s menstrual cycle to prevent possible pregnancy.
Von Willebrand Disease Treatment Market Analysis: Increasing awareness associated with rare diseases, growing healthcare expenditure, and expanding government support for treatment against genetic diseases which are rare are anticipated to lead to extensive growth in the Von Willebrand Disease treatment market over the period of forecast.
Viral Disease Diagnosis Market Trends: Changes in the viral genome act as the primary challenge for the detection of the virus. Due to this, the diagnosis becomes difficult. Hence, various new techniques like microarray techniques and rapid tests are emerging.
HIV-Associated Nephropathy Treatment Market Forecast: HIV-associated nephropathy (HIVAN) treatment is a common practice used to treat the complications associated with HIV, which leads to progressive renal failure and heavy proteinuria.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & chemical and materials, our coverage is expansive, but we ensure even the most niche categories are analysed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR